1. MSB CHOSE to dual list on the NASDAQ. This isn't an inconvenience of someone else's making.
2. Did the need for more cash sneak up on SI? Really? Because that's how you've made it sound? Do you see MSB having any responsibility for MESO at all?
3. You are befriending a person that is ignorant and confused by that ignorance.
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-367
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.020(1.70%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.21 | $1.14 | $9.786M | 8.412M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 78042 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 189626 | 1 |
View Market Depth
| Last trade - 16.10pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.16 |
Change
-0.020 ( 1.47 %) |
||||
| Open | High | Low | Volume | ||
| $1.21 | $1.21 | $1.14 | 1281085 | ||
| Last updated 15.59pm 27/05/2024 ? | |||||
| MSB (ASX) Chart |